Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06015217 · ClinicalTrials.gov registry record · Phase 4
A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT06015217 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 26 participants.
The verdict
NCT06015217, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to assess the efficacy and safety of a Healing Ointment in infants 2-24 months with mild to moderate diaper rash. The main question it aims to answer is: • does a Healing Ointment improve skin texture and smoothness in infants with mild to moderate diaper dermatitis? Participants will use a Healing Ointment on the diaper area with every diaper change, have the Investigator perform efficacy and tolerability assessments, and complete questionnaires regarding subject satisfaction.
Interventions
- DRUG "Cetaphil Healing Ointment"
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-08-25 |
| Est. Completion | 2023-12-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06015217
The ClinicalTrials.gov registry entry for NCT06015217 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which "Cetaphil Healing Ointment" is the first listed.
NCT06015217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06015217 about?
NCT06015217 is a clinical study titled "A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash". The goal of this clinical trial is to assess the efficacy and safety of a Healing Ointment in infants 2-24 months with mild to moderate diaper rash. The main question it aims to answer is: • does a Healing Ointment improve skin texture and smoothness in infants with mild to moderate diaper dermatit...
What is the current status of trial NCT06015217?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2023-08-25. Estimated completion is 2023-12-13.
What interventions are being tested in trial NCT06015217?
The interventions under investigation include: "Cetaphil Healing Ointment" (DRUG).
Who is sponsoring clinical trial NCT06015217?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.